Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5

In Vitro Cellular and Developmental Biology - Animal

Volumn 45, Issue 5-6, 2009, Pages 264-274

  Baxter, Shaneen S ^a,b   Carlson, Lauren A ^a   Mayer, Alejandro M S ^a   Hall, Mary L ^a   Fay, Michael J ^a,b  

^a MIDWESTERN UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

All trans retinoic acid; ASB 2; Cul5; Elongin B C; Granulocytic differentiation; HL 60; ROC2

Indexed keywords

ASB2 PROTEIN, HUMAN; CUL5 PROTEIN, HUMAN; CULLIN; ELONGIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; RETINOIC ACID; RNF7 PROTEIN, HUMAN; SUPEROXIDE; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL MEMBRANE; CELL NUCLEUS; CELL STRAIN HL 60; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GRANULOCYTE; HUMAN; METABOLISM; PATHOLOGY; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL COUNT; CELL DIFFERENTIATION; CELL MEMBRANE; CELL NUCLEUS; CELL SURVIVAL; CULLIN PROTEINS; GENE EXPRESSION REGULATION, LEUKEMIC; GRANULOCYTES; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TRETINOIN; UBIQUITIN-PROTEIN LIGASES;

EID: 67449091669     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-008-9163-4     Document Type: Article

References (73)

1. Aso, T.; Lane, W. S.; Conaway, J. W.; Conaway, R. C. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science. 269: 1439-1443; 1995. doi:10.1126/science.7660129.
2. Ayyub, C.; Sen, A.; Gonsalves, F.; Badrinath, K.; Bhandari, P.; Shashidhara, L. S.; Krishna, S.; Rodrigues, V. Cullin-5 plays multiple roles in cell fate specification and synapse formation during Drosophila Development. Dev. Dyn. 232: 865-875; 2005. doi:10.1002/dvdy.20322.
3. Birnie, G. D. The HL60 cell line: a model system for studying human myeloid cell differentiation. Br. J. Cancer Suppl. 9: 41-45; 1988.
4. Brackman, D.; Lund-Johansen, F.; Aarskog, D. Expression of cell surface antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3, retinoic acid and DMSO. Leuk. Res. 19: 57-64; 1995. doi:10.1016/0145-2126(94)00061-E.
5. Bradsher, J. N.; Jackson, K. W.; Conaway, R. C.; Conaway, J. W. RNA polymerase II transcription factor SIII. I. Identification, purification, and properties. J. Biol. Chem. 268: 25587-25593; 1993a.
6. Bradsher, J. N.; Tan, S.;McLaury, H. J.; Conaway, J.W.; Conaway, R. C. RNA polymerase II transcription factor SIII. II. Functional properties and role in RNA chain elongation. J. Biol. Chem. 268: 25594-25603; 1993b.
7. Breitman, T. R.; Selonick, S. E.; Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 77: 2936- 2940; 1980. doi:10.1073/pnas.77.5.2936.
8. Burnatowska-Hledin,M. A.; Kossoris, J.B.;VanDort,C. J.;Shearer, R. L.; Zhao, P.; Murrey, D. A.; Abbott, J. L.; Kan, C. E.; Barney, C. C. T47D breast cancer cell growth is inhibited by expression of VACM-1, a cul-5 gene. Biochem. Biophys. Res. Commun. 319: 817-825; 2004. doi:10.1016/j.bbrc.2004.05.057.
9. Burnatowska-Hledin, M. A.; Spielman, W. S.; Smith, W. L.; Shi, P.; Meyer, J. M.; Dewitt, D. L. Expression cloning of an AVPactivated, calcium-mobilizing receptor from rabbit kidney medulla. Am. J. Physiol. 268: F1198-F1210; 1995.
10. Byrd, P. J.; Stankovic, T.;McConville, C.M.; Smith,A.D.; Cooper, P. R.; Taylor, A. M. Identification and analysis of expression of human VACM-1, a cullin gene family member located on chromosome 11q22-23. Genome. Res. 7: 71-75; 1997. doi:10.1101/gr.7.1.71.
11. Carter, S. L.; Negrini, M.; Baffa, R.; Gillum, D. R.; Rosenberg, A. L.; Schwartz, G. F.; Croce, C. M. Loss of heterozygosity at 11q22- q23 in breast cancer. Cancer Res. 54: 6270-6274; 1994.
12. Castaigne, S.; Chomienne, C.; Daniel, M. T.; Ballerini, P.; Berger, R.; Fenaux, P.; Degos, L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood. 76: 1704-1709; 1990.
13. Ceremuga, T. E.; Yoa, X. L.; Alam, H. B.; McCabe, J. T. Alterations of Cullin-5 mRNA levels in the rat central nervous system following hemorrhagic shock. Neurol. Res. 25: 211-216; 2003a. doi:10.1179/016164103101201229.
14. Ceremuga, T. E.; Yao, X. L.; Xia, Y.; Mukherjee, D.; McCabe, J. T. Osmotic stress increases Cullin 5 (cul-5) mRNA in the rat cerebral cortex, hypothalamus and kidney. Neurosci. Res. 45: 305-311; 2003b. doi:10.1016/S0168- 0102(02)00228-6.
15. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159; 1987. doi:10.1016/0003-2697 (87)90021-2.
16. Collins, S. J. The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood. 70: 1233-1244; 1987.
17. Collins, S. J.; Gallo, R. C.; Gallagher, R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 270: 347-349; 1977. doi:10.1038/270347a0.
18. Deshaies, R. J. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15: 435-467; 1999. doi:10.1146/ annurev.cellbio.15.1.435.
19. Dias, D. C.; Dolios, G.; Wang, R.; Pan, Z. Q. CUL7: A DOC domaincontaining cullin selectively binds Skp1·Fbx29 to form an SCFlike complex. Proc. Natl. Acad. Sci. U.S.A. 99: 16601-16606; 2002. doi:10.1073/pnas.252646399.
20. Driouch, K.; Briffod, M.; Bièche, I.; Champème, M.-H.; Lidereau, R. Location of several putative genes possibly involved in human breast cancer progression. Cancer Res. 58: 2081-2086; 1998.
21. Duan, H.; Wang, Y.; Aviram, M.; Swaroop, M.; Loo, J. A.; Bian, J.; Tian, Y.; Mueller, T.; Bisgaier, C. L.; Sun, Y. SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents. Mol. Cell Biol. 19: 3145-3155; 1999.
22. Fay, M. J.; Longo, K. A.; Karathanasis, G. A.; Shope, D. M.; Mandernach, C. J.; Leong, J. R.; Hicks, A.; Pherson, K.; Husain, A. Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues. Mol. Cancer 2: 40; 2003. doi:10.1186/1476-4598-2-40.
23. Gallagher, R.; Collins, S.; Trujillo, J.; McCredie, K.; Ahearn,M.; Tsai, S.; Metzgar, R.; Aulakh, R.; Ting, F.; Ruscetti, F.; Gallo, R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood. 54: 713-733; 1979.
24. Giguere, V. Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling. Endocr. Rev. 15: 61-79; 1994. doi:10.1210/er.15.1.61.
25. Givan, A. L. The basics of staining for cell surface proteins. In: Diamond R.; DeMaggio S. (eds) In living color: protocols in flow cytometry and cell sorting. Springer, Berlin, pp 142-164; 2000.
26. Gu, Q.; Tan, M.; Sun, Y. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol- 13-acetate-induced neoplastic transformation. Cancer Res. 67: 3616-3625; 2007. doi:10.1158/0008-5472.CAN-06-4020.
27. Gudmundsson, J.; Barkardottir, R. B.; Eiriksdottir, G.; Baldursson, T.; Arason, A.; Eglisson, V.; Ingvarsson, S. Loss of heterozygosity at chromosome 11 in breast cancer: Association of prognostic factors with genetic alterations. Br. J. Cancer 72: 696-701; 1995.
28. Guibal, F. C.; Moog-Lutz, C.; Smolewski, P.; Di Gioia, Y.; Darzynkiewicz, Z.; Lutz, P. G.; Cayre, Y. E. ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells. J. Biol. Chem. 277: 218-224; 2002. doi:10.1074/jbc. M108476200.
29. Hampton, G. M.; Mannermaa, A.; Winquist, R.; Alavaikko, M.; Blanco, G.; Taskinen, P. J.; Kiviniemi, H.; Newsham, I.; Cavanee, W. K.; Evans, G. A. Loss of heterozygosity in sporadic human breast carcinoma: A common region between 11q22 and 11q23.3. Cancer Res. 54: 4586-4589; 1994.
30. Harris, R.; Ralph, P. Human leukemic models of myelomonocytic development: A review of the HL-60 and U937 cell lines. J. Leukoc. Biol. 37: 407-422; 1985.
31. Hershko, A.; Ciechanover, A. The Ubiquitin System. Annu. Rev. Biochem. 67: 425-479; 1998. doi:10.1146/annurev.biochem.67.1.425.
32. Heuze, M. L.;Guibal, F. C.; Banks, C.A.; Conaway, J.W.; Conaway, R. C.; Cayre, Y. E.; Benecke, A.; Lutz, P. G. ASB-2 is an Elongin BCinteracting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex. J. Biol. Chem. 280: 5468-5474; 2005. doi:10.1074/jbc.M413040200.
33. Heuze, M. L.; Lamsoul, I.; Baldassarre, M.; Lad, Y.; Leveque, S.; Razinia, Z.; Moog-Lutz, C.; Calderwood, D. A.; Lutz, P. G. ASB2 targets filamins A and B to proteasomal degradation. Blood. 2008, (in press). doi:10.1182/blood-2007-12-128744
34. Hilton, D. J.; Richardson, R. T.; Alexander, W. S.; Viney, E. M.; Wilson, T. A.; Sprigg, N. S.; Starr, R.; Nicholson, S. E.;Metcalf, D.; Nicola, N. A. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. U.S.A. 95: 114-119; 1998. doi:10.1073/pnas.95.1.114.
35. Huang, M. E.; Ye, Y. C.; Chen, S. R.; Chai, J. R.; Lu, J. X.; Zhoa, L.; Gu, L. J.;Wang, Z. Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72: 567-572; 1988.
36. Iwai, K.; Yamanaka, K.; Kamura, T.; Minato, N.; Conaway, R. C.; Conaway, J. W.; Klausner, R. D.; Pause A. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. U.S.A. 96: 12436-12441; 1999. doi:10.1073/pnas.96.22.12436.
37. Kalla, C.; Scheuermann, M. O.; Kube, I.; Schlotter, M.; Mertens, D.; Döhner, H.; Stilgenbauer, S.; Lichter, P. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: Evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B. Eur. J. Cancer 43: 1328-1335; 2007. doi:10.1016/j.ejca.2007.02.005.
38. Kamura, T.; Burian, D.; Yan, Q.; Schmidt, S. L.; Lane, W. S.; Querido, E.; Branton, P. E.; Shilatifard, A.; Conaway, R. C.; Conaway, J. W. MUF1, a novel Elongin BC-interacting leucinerich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J. Biol. Chem. 276: 29748-2953; 2001. doi:10.1074/jbc.M103093200.
39. Kamura, T.; Koepp, D. M.; Conrad,M. N.; Skowyra, D.;Moreland, R. J.; Iliopoulos, O.; Lane, W. S.; Kaelin, W. G. Jr.; Elledge, S. J.; Conaway, R. C.; Harper, J. W.; Conaway, J. W. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science. 284: 657-661; 1999. doi:10.1126/ science.284.5414.657.
40. Kamura,T.;Sato, S.;Haque, D.;Liu,L.; Kaelin,W. G. Jr;Conaway,R.C.; Conaway, J. W. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12: 3872-3881; 1998. doi:10.1101/gad.12.24.3872.
41. Kibel, A.; Iliopoulos, O.; DeCaprio, J. A.; Kaelin,W. G. Jr. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science. 269: 1444-1446; 1995. doi:10.1126/science.7660130.
42. Kile, B. T.; Schulman, B. A.; Alexander, W. S.; Nicola, N. A.; Martin, H. M. E.; Hilton, D. J. The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 27: 235-241; 2002. doi:10.1016/S0968-0004(02)02085-6.
43. Kile, B. T.; Viney, E. M.;Wilson, T. A.; Brodnicki, T. C.; Cancilla,M. R.; Herlihy, A. S.; Croker, B. A.; Baca, M.; Nicola, N. A.; Hilton, D. J.; Alexander, W. S. Cloning and characterization of the genes encoding the ankyrin repeat and SOCS box-containing proteins Asb-1, Asb-2, Asb-3 and Asb-4. Gene. 258: 31-41; 2000. doi:10.1016/S0378-1119(00)00402-9.
44. Kipreos, E. T.; Lander, L. E.; Wing, J. P.; He, W. W.; Hedgecock, E. M. cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell. 85: 829-839; 1996. doi:10.1016/S0092- 8674(00)81267-2.
45. Kitareewan, S.; Pitha-Rowe, I.; Sekula, D.; Lowrey, C. H.; Nemeth, M. J.; Golub, T. R.; Freemantle, S. J.; Dimitrovsky, E. UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 99: 3806-3811; 2002. doi:10.1073/pnas.052011299.
46. Kohroki, J.; Fujita, S.; Itoh, N.; Yamada, Y.; Imai, H.; Yumoto, N.; Nakanishi, T.; Tanaka, K. ATRA-regulated ASB-2 gene induced in differentiation of HL-60 leukemia cells. FEBS Lett. 505: 223-228; 2001. doi:10.1016/S0014- 5793(01)02829-0.
47. Kohroki, J.; Nishiyama, T.; Nakamura, T.; Masuho, Y. ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes. FEBS Lett. 579: 6796-6802; 2005. doi:10.1016/j. febslet.2005.11.016.
48. Krebs, D. L.; Hilton, D. J. SOCS: physiological suppressors of cytokine signaling. J. Cell Sci. 113: 2813-2819; 2000.
49. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685; 1970. doi:10.1038/227680a0.
50. Li, B.; Yang, F. C.; Clapp, D. W.; Chun, K. T. Enforced expression of CUL-4A interferes with granulocytic differentiation and exit from the cell cycle. Blood. 101: 1769-1776; 2003. doi:10.1182/blood- 2002-05-1517.
51. Mathias, N.; Johnson, S. L.; Winey, M.; Adams, A. E. M.; Goetsch, L.; Pringle, J. R.; Byers, B.; Goebl, M. G. Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteins. Mol. Cell Biol. 16: 6634- 6643; 1996.
52. Mayer, A. M. S.; Brenic, S.; Glaser, K. B. Pharmacological targeting of signaling pathways in protein kinase C-stimulated superoxide generation in neutrophil-like HL-60 cells: effect of phorbol ester, arachidonic acid and inhibitors of kinase(s), phosphatase(s) and phospholipase A2 1. J. Pharmacol. Exp. Ther. 279: 633-644; 1996.
53. Mayer, A. M. S.; Brenic, S.; Stocker, R.; Glaser, K. B. Modulation of superoxide generation in in vivo lipopolysaccharide-primed rat alveolar macrophages by arachidonic acid and inhibitors of protein kinase C, phospholipase A2, protein serine-threonine phosphatase(s), protein tyrosine kinases(s) and phosphatase(s). J. Pharmacol. Exp. Ther. 274: 427-436; 1995.
54. Negrini,M.; Rasio, D.; Hampton,G. M.; Sabbioni, S.; Rattan, S.; Carter, S. L.; Rosenberg, A. L.; Schwartz, G. F.; Shiloh, Y.; Cavenee, W. K.; Croce, C. M. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: Identification of a new region at 11q23.3. Cancer Res. 55: 3003-3007; 1995.
55. Nikolaev, A. Y.; Li, M.; Puskas, N.; Qin, J.; Gu, W. Parc: a cytoplasmic anchor for p53. Cell. 112: 29-40; 2003. doi:10.1016/S0092-8674(02)01255-2.
56. Ohta, T.; Michel, J. J.; Schottelius, A. J.; Xiong, Y. ROC1, a homolog of APC11, represents a family of Cullin partners with an associated ubiquitin ligase activity. Mol. Cell. 3: 535-541; 1999a. doi:10.1016/S1097-2765(00)80482- 7.
57. Ohta, T.; Michel, J. J.; Xiong, Y. Association with cullin partners protects ROC proteins from proteasome-dependent degradation. Oncogene. 18: 6758-6766; 1999b. doi:10.1038/sj.onc.1203115.
58. Ohta, T.; Xiong, Y. Phosphorylation- and SKP1-independent in vitro ubiquination of E2F1 by multiple ROC-Cullin ligases. Cancer Res. 61: 1347-1353; 2001.
59. Olins, A. L.; Olins, D. E. Cytoskeletal influences on nuclear shape in granulocytic HL-60 cells. BMC Cell Biol. 5: 30; 2004. doi:10.1186/1471-2121-5- 30.
60. Seol, J. H.; Feldman, R. M. R.; Zachariae, W.; Shevchenko, A.; Correll, C. C.; Lyapina, S.; Chi, Y.; Galova, M.; Claypool, J.; Sandmeyer, S.; Nasmyth, K.; Shevchenko, A.; Deshaies, R. J. Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34. Genes Dev. 13: 1614-1626; 1999. doi:10.1101/ gad.13.12.1614.
61. Sun, Y.; Tan, M.; Duan, H.; Swaroop, M. SAG/ROC/Rbx/Hrt, a zinc RING finger gene family: Molecular cloning, biochemical properties, and biological functions. Antioxid. Redox. Signal 3: 635-650; 2001. doi:10.1089/ 15230860152542989.
62. Tamayo, P.; Slonim, D.; Mesirov, J.; Zhu, Q.; Kitareewan, S.; Dmitrovsky, E.; Lander, E. S.; Golub, T. R. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. U.S.A. 96: 2907-2912; 1999. doi:10.1073/pnas.96.6.2907.
63. Tomlinson, I. P. M.; Strickland, J. E.; Lee, A. S. G.; Bromley, L.; Evans, M. F.; Morton, J.; McGee, J. O. D. Loss of hterozygosity on chromosome 11q in breast cancer. J. Clin. Pathol. 48: 424- 428; 1995. doi:10.1136/jcp.48.5. 424.
64. Trayner, I. D.; Bustorff, T.; Etches, A. E.; Mufti, G. J.; Foss, Y.; Farzaneh, F. Changes in antigen expression on differentiating HL60 cells treated with dimetylsulphoxide, all-trans retinoic acid, α 1,25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol- 13-acetate. Leuk. Res. 22: 537-547; 1998. doi:10.1016/ S0145-2126(98)00041-1.
65. Tsiftsoglou, A. S.; Robinson, S. H. Differentiation of Leukemic Cell Lines: A review focusing on Murine Erythroleukemia and Human HL-60 Cells. Int. J. Cell Cloning 3: 349-366; 1985.
66. Van Dort, C.; Zhao, P.; Parmelee, K.; Capps, B.; Poel, A.; Listenberger, L.; Kossoris, J.; Wasilevich, B.; Murrey, D.; Clare, P.; Burnatowska-Hledin, M. VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways. Am. J. Physiol. Cell Physiol. 285: C1386-C1396; 2003.
67. Warrell, R. P. Jr; Frankel, S. R.; Miller, W. H.; Scheinberg, D. A.; Itri, L. M.; Hittelman, W. N.; Vyas, R.; Andreeff, M.; Tafuri, A.; Jakubowski, A.; Gabrilove, J.; Gordon, M. S.; Dmitrovsky, E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N. Engl. J. Med. 324: 1385-1393; 1991.
68. Willems, A. R.; Schwab, M.; Tyers, M. A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin. Biochim. Biophys. Acta 1695: 133-170; 2004. doi:10.1016/j.bbamcr.2004.09.027.
69. Winqvist, R.; Hampton, G. M.; Mannermaa, A.; Blanco, G.; Alavaikko, M.; Kiviniemi, H.; Taskinen, P. J.; Evans, G. A.; Wright, F. A.; Newsham, I.; Cavenee, W. K. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res. 55: 2660-2664; 1995.
70. Yang,G.Y.; Pang, L.; Ge,H. L.; Tan,M.;Ye,W.; Liu,X.H.; Huang, F. P.; Wu, D. C.; Che, X. M.; Song, Y.; Wen, R.; Sun, Y. Attenuation of ischemia-induced mouse brain injury by SAG, a redox-inducible antioxidant protein. J. Cereb. Blood Flow Metab. 21: 722-733; 2001. doi:10.1097/00004647-200106000-00010.
71. Yao, X. L.; Liu, J.; Lee, E.; Ling, G. S. F.; McCabe, J. T. Cullin 5 gene expression in the rat cerebral cortex and hippocampus following traumatic brain injury (TBI). Neurosci. Lett. 409: 65-69; 2006. doi:10.1016/j.neulet.2006.09. 015.
72. Yu,H.;Peters, J.M.;King,R.W.; Page,A.M.; Hieter, P.;Kirschner,M.W. Identification of a cullin homology region in a subunit of the anaphase-promoting complex. Science. 279: 1219-22; 1998. doi:10.1126/science. 279.5354.1219.
73. Yuan, J. S.; Reed, A.; Chen, F.; Stewart, N. C. Jr. Statistical analysis of real-time PCR data. BMC Bioinformatics. 7: 85; 2006. doi:10.1186/1471-2105-7- 85.